Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China · Delayed Price · Currency is CNY 4.280
-0.100 (-2.28%)
Nov 13, 2026, 3:04 PM CST
SHE:000597 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,452 | 7,075 | 7,503 | 8,243 | 8,809 | 8,145 |
Revenue Growth | -5.77% | -5.70% | -8.98% | -6.42% | 8.15% | 10.30% |
Gross Profit Gross Profit Growth | 2,075 | 2,430 | 2,761 | 3,118 | 3,252 | 3,089 |
Operating Income Operating Income Growth | 97.05 | 258.22 | 475.95 | 366.2 | 219.56 | 210.63 |
Net Income Net Income Growth | 189.46 | 260.07 | 409.85 | 358.46 | 350.25 | 99.03 |
Earnings Per Share EPS Growth | 0.13 | 0.18 | 0.29 | 0.25 | 0.25 | 0.07 |
EPS Growth | -50.53% | -37.93% | 16.00% | 0% | 257.14% | 600.00% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 3,898 | 4,291 | 4,724 | 5,085 | 4,624 |
Pharmaceutical Business Pharmaceutical Business Growth | 3,026 | 3,053 | 3,373 | 3,568 | 3,354 |
Others Others Growth | 150.09 | 158.16 | 146.32 | 156.57 | 167.33 |
Total Total Growth | 7,075 | 7,503 | 8,243 | 8,809 | 8,145 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,225 | 3,602 | 4,468 | 5,651 | 3,845 | 2,550 |
Total Debt Total Debt Growth | 1,823 | 2,112 | 1,593 | 2,183 | 2,198 | 2,488 |
Net Cash (Debt) Net Cash Growth | 2,402 | 1,491 | 2,876 | 3,468 | 1,647 | 62.17 |
Net Cash Growth | 7.31% | -48.17% | -17.08% | 110.51% | 2549.68% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.66 | 1.03 | 2.03 | 2.42 | 1.18 | 0.04 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 917.03 | 1,106 | 758.76 | 586.75 | 1,109 | 746.51 |
Capital Expenditures CapEx Growth | -82.21 | -97.78 | -159.43 | -235.43 | -244.13 | -119.81 |
Free Cash Flow Free Cash Flow Growth | 834.82 | 1,009 | 599.34 | 351.32 | 864.44 | 626.7 |
Free Cash Flow Growth | 33.68% | 68.29% | 70.59% | -59.36% | 37.94% | 267.49% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.17% | 34.35% | 36.81% | 37.83% | 36.92% | 37.93% |
Operating Margin | 1.50% | 3.65% | 6.34% | 4.44% | 2.49% | 2.59% |
Pretax Margin | 3.14% | 4.31% | 7.92% | 5.92% | 5.96% | 1.48% |
Profit Margin | 2.94% | 3.68% | 5.46% | 4.35% | 3.98% | 1.22% |
FCF Margin | 12.94% | 14.26% | 7.99% | 4.26% | 9.81% | 7.69% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.055 | 0.055 | 0.100 | 0.100 | 0.100 | 0.014 |
Dividend Per Share Growth | -45.00% | -45.00% | 0% | 0% | 614.29% | 75.00% |
Dividend Yield | 1.28% | 1.05% | 1.90% | 1.87% | 1.58% | 0.22% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.63 | 28.64 | 18.38 | 21.33 | 25.84 | 84.66 |
Forward PE | - | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 |
P/FCF Ratio | 7.33 | 7.39 | 12.57 | 21.76 | 10.47 | 13.38 |
PS Ratio | 0.95 | 1.05 | 1.00 | 0.93 | 1.03 | 1.03 |